Press Releases

Date	Title	Company
03-Oct-2023	Renal Biomarkers Market Poised for Remarkable Growth, Anticipated to Surpass US$ 2.6 Billion by 2032	MARKITWIRED
03-Oct-2023	Ganymed Robotics Announces Appointment of Seasoned Leadership Team to Bring to Market Its Next Generation Surgical Technology	Businesswire
03-Oct-2023	Takeda Fornece Atualização sobre EXKIVITY® (mobocertinib)	Businesswire
03-Oct-2023	Portable Oxygen Concentrators Market Breathing Easy Towards a US$ 5.0 Billion Milestone by 2032, Set to Surpass Expectations	MARKITWIRED
03-Oct-2023	Roche to present new key clinical and real-world data at ECTRIMS-ACTRIMS 2023 showcasing strength of long-term outcomes in MS and NMOSD	Roche
03-Oct-2023	Sanofi announces agreement for potential first-in-class vaccine against extraintestinal pathogenic E. coli	Sanofi
03-Oct-2023	Takeda Provides Update on EXKIVITY® (mobocertinib)	Takeda
03-Oct-2023	R21/Matrix-M™ Malaria Vaccine with Novavax’s Adjuvant Technology Receives WHO Recommendation	Novavax
03-Oct-2023	Oxford BioTherapeutics Announces Partner Boehringer Ingelheim Received U.S. FDA Fast Track Designation for BI 764532 for the Treatment of Extensive Stage Small Cell Lung Cancer and Extrapulmonary Neuroendocrine Cancers	Oxford BioTherapeutics
03-Oct-2023	Biohaven Announces Pricing of $225 Million Public Offering of Common Shares	Biohaven
03-Oct-2023	Immix Biopharma Announces 72-Patient NXC-201 Clinical Data at the IMS 20th Annual Meeting, 95% Overall Response Rate in Multiple Myeloma	Immix Biopharma
03-Oct-2023	Cassava Sciences Completes Patient Enrollment for Pivotal Phase 3 Clinical Trial of Oral Simufilam in Alzheimer’s Disease	Cassava Sciences
03-Oct-2023	King Faisal Specialist Hospital & Research Centre Achieves Medical Milestone with World's First Fully Robotic Liver Transplant	King Faisal Specialist Hospital & Research Centre
03-Oct-2023	The Oxford-Harrington Rare Disease Centre Launches Pioneering Therapeutics Accelerator to Advance Innovative Treatments for Rare Diseases	The Oxford-Harrington Rare Disease Centre
03-Oct-2023	Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System	Amber Implants
03-Oct-2023	Ophthalmic Lasers Market: Envisioning a Bright Future, Projected to Reach US$ 1.3 Billion by 2030	MARKITWIRED
03-Oct-2023	Oxford BioTherapeutics Announces Partner Boehringer Ingelheim Received U.S. FDA Fast Track Designation for BI 764532 for the Treatment of Extensive Stage Small Cell Lung Cancer and Extrapulmonary Neuroendocrine Cancers	Oxford BioTherapeutics
03-Oct-2023	President of The Physiological Society congratulates 2023 Nobel Prize winner	The Physiological Society
03-Oct-2023	Agility in the spotlight for 2024 pharma sector, says MM Packaging	MM Packaging
03-Oct-2023	Traditional Wound Management Market: Ancient Remedies Thrive with a Valuation of US$ 6.9 Billion in 2032	MARKITWIRED